INTELLECTUAL PROPERTY SECURITY AGREEMENTIntellectual Property Security Agreement • September 9th, 2022 • Curative Biotechnology Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 9th, 2022 Company Industry JurisdictionThis Intellectual Property Security Agreement (“IP Security Agreement”) dated as of March 2, 2022, is made and entered into by and among Curative Biotechnology, Inc., a Florida corporation (the “Company”), any subsidiary of the Company that is a signatory hereto either now joined or joined in the future (such subsidiaries, together with the Company, the “Debtors”), and Puritan Partners LLC, as Holder of the 12.5% Senior Secured Notes due March 2, 2023 in aggregate principal amount of $1,142,857.14 (the “Notes”) of the Company.
INTELLECTUAL PROPERTY SECURITY AGREEMENTIntellectual Property Security Agreement • March 25th, 2022 • Curative Biotechnology Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 25th, 2022 Company Industry JurisdictionThis Intellectual Property Security Agreement (“IP Security Agreement”) dated as of March 2, 2022, is made and entered into by and among Curative Biotechnology, Inc., a Florida corporation (the “Company”), any subsidiary of the Company that is a signatory hereto either now joined or joined in the future (such subsidiaries, together with the Company, the “Debtors”), and [_______], as Holder of the 12.5% Senior Secured Notes due March 2, 2023 in aggregate principal amount of $1,142,857.14 (the “Notes”) of the Company.